NEWS RELEASE 11-JUL-2024 Waltham — July 11, 2024 — An investigational medication designated TAS-303 shows efficacy and safety in treatment of women with stress urinary incontinence (SUI), reports a placebo-controlled clinical trial in the August issue of The Journal of Urology®, an Official Journal of the American Urological Association (AUA). The journal is published in the...
Category: <span>Pharmaceutical Updates</span>
Post
New Options for Refractory Gout Are Showing Promise in Late-Phase Trials
Medscape Medical News > Conference News > EULAR 2024 Ted Bosworth July 09, 2024 VIENNA — Safe and effective options for lowering serum uric acid (sUA) in patients with gout who are refractory to conventional therapies appear to be near, judging from phase 2 and 3 trials that produced positive results at the European Alliance...
Post
Physicians can significantly reduce antibiotic use without compromising treatment
JUNE 28, 2024 by University of Copenhagen Credit: Unsplash/CC0 Public DomainOlder GPs are more likely to prescribe antibiotics than their younger colleagues. A more cautious approach will not degrade treatment—and it can help fight antibiotic resistance that could soon kill millions of people annually. The discovery was made in a new study from the Department...
Post
Most kids get antibiotics for pink eye, study shows. Experts say they’re usually not needed
JUNE 28, 2024 by Devi Shastri This microscope photo provided by the Centers for Disease Control and Prevention shows gram-negative, Haemophilus influenzae bacteria. The microorganism is one of the more common causes of pink eye in children. Credit: William B. Cherry/CDC via APDoctors are prescribing antibiotics to most kids and teens who have pink eye,...
Post
FDA Approves New Treatment for Primary Axillary Hyperhidrosis
Medscape Medical News > FDA Approvals Doug Brunk June 25, 2024 The Food and Drug Administration has approved a topical anticholinergic, sofpironium topical gel, 12.45%, for the treatment of primary axillary hyperhidrosis in adults and children aged ≥ 9 years. According to a press release from Botanix Pharmaceuticals, which developed the product and will market...
Post
Genetic study points to oxytocin as possible treatment for obesity and postnatal depression
JULY 2, 2024 by University of Cambridge Credit: Unsplash/CC0 Public DomainScientists have identified a gene which, when missing or impaired, can cause obesity, behavioral problems and, in mothers, postnatal depression. The discovery, reported in Cell, may have wider implications for the treatment of postnatal depression, with a study in mice suggesting that oxytocin may alleviate...
Post
Study shows sedative exams like endoscopy may require prolonged fasting for semaglutide users
JULY 3, 2024 by D’Or Institute for Research and Education Credit: CC0 Public DomainA study published in the Journal of Clinical Anesthesia investigated the relationship between semaglutide use and residual gastric content in patients undergoing upper gastrointestinal endoscopy (EGD). Conducted by researchers at the D’Or Institute for Research and Education (IDOR), the retrospective study analyzed...
Post
Scientists unravel life-saving effect of dexamethasone in COVID-19
NEWS RELEASE 3-JUL-2024 Study in “Cell” Peer-Reviewed PublicationDZNE – GERMAN CENTER FOR NEURODEGENERATIVE DISEASES Dexamethasone is one of the most important drugs in the treatment of severe COVID-19, but patients respond very differently to the therapy. Researchers at the German Center for Neurodegenerative Diseases (DZNE) and Charité – Universitätsmedizin Berlin have now discovered how the...
Post
Experimental drug supercharges medicine that reverses opioid overdose
NEWS RELEASE 3-JUL-2024 Adding newly ID’d compound makes naloxone more potent, longer lasting, mouse study shows Peer-Reviewed PublicationWASHINGTON UNIVERSITY SCHOOL OF MEDICINE The ongoing opioid epidemic in the U.S. kills tens of thousands of people every year. Naloxone, sold under the brand name Narcan, has saved countless lives by reversing opioid overdoses. But new and...
Post
Popular prescription weight loss drugs linked to uncommon blinding condition
NEWS RELEASE 3-JUL-2024 A new Mass Eye and Ear-led study is the first to discover that people prescribed semaglutide, sold as Ozempic and Wegovy, have a higher risk of developing a form of blindness due to optic nerve disease known as non-arteritic anterior ischemic optic neurop Peer-Reviewed PublicationMASS EYE AND EAR A new study led...